Yan Ming's Form 4 filing
Cytek Biosciences, Inc. (CTKB) · filed Apr 11, 2024
- Accession no.
- 0001415889-24-010714
- Filed
- Apr 11, 2024
- Trade date
- Apr 9, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $13.3K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Yan MingCIK 0001874041 | Director, Officer (CHIEF TECHNOLOGY OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 9, 2024 | Common Stock | SSaleDisposed | −1,500 | $7.00 | −$10,500 | 6,008,902 | Direct | |
| Apr 9, 2024 | Common Stock | SSaleDisposed | −400 | $7.01 | −$2,804 | 6,008,502 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.